About 1 result found for searched term "1312299-39-0" (0.127 seconds)
Cat.No. | Name | Target |
---|---|---|
M24605 | Concizumab | Others |
NN 7415; mAb 2021 Anti-TFPI Recombinant Antibody | ||
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.